Mark Jeffrey DeLong, Senior Vice President at Apellis Pharmaceuticals, Inc. (APLS), sold 7,000 shares at $52.53 ($368K) on 2022-04-20, disclosed to the SEC on 2022-04-22.
Open-market sale of $368k APLS by Senior Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| APLS | SELL | 2026-01-21 | $26K | — | Filing → |
| APLS | SELL | 2026-01-15 | $39K | — | Filing → |
| APLS | SELL | 2025-02-12 | $10K | — | Filing → |